Immune, metabolic and multisystem ocular clues
Key Takeaways
Destructive scleral or peripheral corneal inflammation can signal systemic vasculitis and requires infection exclusion.
Dryness, hearing loss, cartilage pain, bowel disease and pulmonary symptoms guide different inflammatory differentials.
Corneal deposits need medication and metabolic assessment; their appearance alone is not a complete diagnosis.
Developmental and genetic disorders require individualized visual assessment and rehabilitation.
Build a systemic differential from the tissue involved
Ocular inflammation, dryness, deposits and developmental abnormalities can indicate multisystem disease. Connective-tissue disease, infection, metabolic storage and chromosomal disorders produce different patterns. The examination should guide the history and investigations rather than triggering a universal laboratory panel. Ask about joints, skin, mouth, chest, bowel, kidneys, hearing, neurological symptoms and family history.
Record whether the main tissue is cornea, sclera, uvea, retina, nerve or orbit. A painful necrotizing scleral process carries a different systemic concern from mild bilateral dryness. Multiple affected tissues may point toward vasculitis, granulomatous disease or a syndromic diagnosis. The ophthalmologist should recognize the pattern and arrange the relevant specialist evaluation without claiming that an ocular sign alone proves a systemic disease.
Autoimmune and connective-tissue disease
Rheumatoid disease and systemic vasculitis can cause scleritis and peripheral ulcerative keratitis. Destructive disease requires prompt systemic assessment and exclusion of infection. Treating only with lubricants or topical steroids may leave a life-threatening vasculitic process unrecognized. Systemic lupus can involve the retina and vessels, with the pattern and associated systemic activity guiding therapy.
Sjögren disease can cause severe aqueous-deficient dry eye, often with oral dryness and systemic manifestations. Symptomatic topical treatment is important, while refractory surface disease may require selected anti-inflammatory or serum-based treatment. Systemic immunosuppression is directed at active systemic disease and is not automatically the answer to every dry-eye symptom. Coordinate with rheumatology and oral care, and monitor for complications of severe surface breakdown.
Relapsing polychondritis can combine painful cartilage inflammation with scleral or other ocular disease. Cogan syndrome classically links interstitial keratitis with audiovestibular symptoms; atypical ocular presentations also occur. New hearing loss or severe balance symptoms in an inflammatory eye patient requires prompt assessment. Do not ask only about joints when screening for systemic inflammatory associations.
Pulmonary, bowel and infectious context
Sarcoidosis can affect uvea, lacrimal tissue, orbit and nerves, with pulmonary or other systemic findings. Tuberculosis and syphilis are important infectious mimics. A granulomatous appearance is descriptive and does not establish a noninfectious cause. Interpret chest imaging, serology and tissue findings with the clinical phenotype and exposure context.
Inflammatory bowel disease can be associated with episcleritis, scleritis or uveitis. Ocular activity may not track bowel symptoms exactly. In a patient taking immunomodulators, infection risk and drug effects remain relevant. HIV, transplant status or systemic immunosuppression changes the differential of retinal and surface infections and the urgency of sampling and treatment.
| Extraocular clue | Ocular association to consider | Practical response |
|---|---|---|
| Dry mouth and systemic dryness | Sjögren disease | Surface care and systemic assessment |
| Hearing or vestibular change | Cogan syndrome or other syndromic disease | Urgent relevant specialist review |
| Cartilage pain | Relapsing polychondritis | Inflammatory and systemic work-up |
| Bowel inflammation | Associated uveitis or scleral disease | Coordinate treatment and infection risk |
| Pulmonary or granulomatous features | Sarcoid, TB and mimics | Cause-specific investigation |
Metabolic deposits and inherited tissue disorders
Wilson disease can produce a Kayser–Fleischer ring in Descemet membrane and, less commonly, a sunflower cataract. A ring-like corneal deposit requires a systemic hepatic and neurological assessment when compatible; absence of a visible ring does not exclude every form of Wilson disease. Fabry disease can produce cornea verticillata with systemic renal, cardiac or neurological features. Similar whorl deposits can occur with medication, so history matters.
Amyloid can involve conjunctiva, orbit or other ocular tissues. Localized amyloid and systemic disease have different implications; tissue confirmation and systemic assessment are selected accordingly. Storage disorders may cause corneal clouding or a cherry-red macular appearance. A cherry-red spot reflects contrast with surrounding opaque retina and has vascular as well as metabolic causes, so the age and clinical course are essential.
Marfan syndrome, homocystinuria and related disorders may cause ectopia lentis with different systemic risks. Avoid inferring the diagnosis solely from the direction of lens displacement. Ehlers–Danlos and other connective-tissue disorders can affect scleral or corneal integrity, making surgical planning and trauma counselling important. Albinism affects pigmentation and visual development, with nystagmus and foveal hypoplasia; assess refraction, low-vision needs and relevant systemic or genetic subtype.
Developmental and skin clues
Down syndrome has associations including refractive problems, strabismus, cataract and keratoconus; screening and cooperative examination should be adapted to developmental needs. Other chromosomal and skeletal syndromes can have coloboma, lens or orbital abnormalities. Use a developmental history and genetics assessment rather than treating a syndrome name as a substitute for examining each eye.
Rosacea and atopic disease can affect lids, tear film and cornea. Severe atopic keratoconjunctivitis may cause scarring and sight-threatening complications, requiring more than occasional antihistamine drops. Pigmentary and vascular skin findings can direct assessment for phakomatoses, already addressed with their specific systemic pathways.
Clinical application
A patient with corneal melt and painful joints needs urgent vasculitic and infectious assessment. Interstitial keratitis with new hearing loss raises a different systemic concern. Whorl-like corneal deposits require a medication and metabolic history. Describe the tissue, associated clues and the investigation or referral that changes care.
Sources: EULAR Sjögren recommendations and EBO curriculum.
Sections you finish are checked off in the contents.